ArticleIndian journal of anaesthesia2026
Clinical performance of i-gel and i-gel Plus for airway management of obese patients: A prospective randomised controlled trial.
Article in Indian journal of anaesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Complications of emergency airway management: Improving rapid sequence induction with the SALAD technique.Indian journal of anaesthesia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The i-gel Plus (i-gelP) is a refined version of i-gel supraglottic airway device (SAD), featuring an extended cuff tip, an intubation ramp, and a broader gastric channel, which may contribute to better performance. However, despite the anatomical and physiological airway challenges in obese individuals, scientific data on its use in this population are unavailable. The aim of this trial was to compare i-gel and i-gelP for perioperative airway management in obese patients. Methods: It is a prospective, single-centre, single-blind, randomised controlled trial. Seventy-six adult obese patients (body mass index ≥30 kg/m²) of American Society of Anesthesiologists physical status II-III, undergoing elective surgery, were randomised for airway management using either i-gel or i-gelP. The primary outcome variable was oropharyngeal leak pressure (OLP). The secondary outcomes were first-attempt and overall insertion success rates, leak fraction, insertion time, ease of device placement, fibreoptic glottic view, and complications. Statistical comparison was done using unpaired Results: Three patients were excluded after failed SAD insertion, leaving 36 in the i-gel group and 37 in the i-gelP group for analysis. Demographic characteristics were comparable between groups. i-gelP achieved significantly higher OLP than i-gel {34.57 (2.85) [33.62-35.52] vs 27.67 (2.88) [26.69-28.64] cm H Conclusion: I-gelP is superior to i-gel for managing the airway of obese patients, mainly class 1 obesity during elective surgery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.